These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27195521)

  • 1. Selective effects of a fiber chimeric conditionally replicative adenovirus armed with hep27 gene on renal cancer cell.
    Fang L; Cheng Q; Liu W; Zhang J; Ge Y; Zhang Q; Li L; Liu J; Zheng J
    Cancer Biol Ther; 2016 Jun; 17(6):664-73. PubMed ID: 27195521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma.
    Chen W; Wu Y; Liu W; Wang G; Wang X; Yang Y; Chen W; Tai Y; Lu M; Qian Q; Zhang Q; Chen G
    Cancer Lett; 2011 Aug; 307(1):93-103. PubMed ID: 21504839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5/35 fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells.
    He X; Liu J; Yang C; Su C; Zhou C; Zhang Q; Li L; Wu H; Liu X; Wu M; Qian Q
    Hum Gene Ther; 2011 Mar; 22(3):283-92. PubMed ID: 20846024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL-24 enhances the antitumor effect of temozolomide against melanoma.
    Yang M; Yang C; Tao Y; Tang J; Huang Q; Guo W; Feng S; Jiang A; Xu X; Jiang G; Liu Y
    Cancer Med; 2018 Dec; 7(12):5928-5942. PubMed ID: 30406970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.
    Takagi-Kimura M; Yamano T; Tamamoto A; Okamura N; Okamura H; Hashimoto-Tamaoki T; Tagawa M; Kasahara N; Kubo S
    Cancer Sci; 2013 Nov; 104(11):1433-9. PubMed ID: 23962292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53.
    Deisenroth C; Thorner AR; Enomoto T; Perou CM; Zhang Y
    Mol Cell Biol; 2010 Aug; 30(16):3981-93. PubMed ID: 20547751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells.
    Iguchi K; Sakurai F; Tomita K; Katayama K; Yamaguchi T; Kawabata K; Tagawa M; Kawabata M; Shirakawa T; Mizuguchi H
    Cancer Gene Ther; 2012 Feb; 19(2):118-25. PubMed ID: 22076042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell.
    Liu J; Fang L; Cheng Q; Li L; Su C; Zhang B; Pei D; Yang J; Li W; Zheng J
    Cancer Sci; 2012 Oct; 103(10):1880-8. PubMed ID: 22775978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis.
    Zheng JN; Pei DS; Sun FH; Liu XY; Mao LJ; Zhang BF; Wen RM; Xu W; Shi Z; Liu JJ; Li W
    Cancer Biol Ther; 2009 Apr; 8(7):599-606. PubMed ID: 19305163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy.
    Yang M; Yang CS; Guo W; Tang J; Huang Q; Feng S; Jiang A; Xu X; Jiang G; Liu YQ
    Cancer Biol Ther; 2017 Nov; 18(11):833-840. PubMed ID: 29144842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fiber-substituted conditionally replicating adenovirus for oncolysis of human renal carcinoma cells.
    Nagaya H; Tagawa M; Hiwasa K; Terao S; Kanno T; Nishizaki T; Gotoh A
    Anticancer Res; 2012 Jul; 32(7):2985-9. PubMed ID: 22753762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic adenovirus armed with shRNA targeting MYCN gene inhibits neuroblastoma cell proliferation and in vivo xenograft tumor growth.
    Li Y; Zhang B; Zhang H; Zhu X; Feng D; Zhang D; Zhuo B; Li L; Zheng J
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):933-41. PubMed ID: 23443256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.
    Cao W; Tian J; Li C; Gao Y; Liu X; Lu J; Wang Y; Wang Z; Svatek RS; Rodriguez R
    Virol J; 2017 Aug; 14(1):149. PubMed ID: 28789701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
    Zhong S; Yu D; Wang Y; Qiu S; Wu S; Liu XY
    Acta Oncol; 2010; 49(1):91-9. PubMed ID: 19734998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
    Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
    Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma.
    Fang L; Tian W; Zhang C; Wang X; Li W; Zhang Q; Zhang Y; Zheng J
    Pharmacol Res; 2023 Mar; 189():106701. PubMed ID: 36796464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies.
    Wang G; Li G; Liu H; Yang C; Yang X; Jin J; Liu X; Qian Q; Qian W
    J Gene Med; 2009 Jun; 11(6):477-85. PubMed ID: 19340843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PD-L1 tropism-expanded oncolytic adenovirus enhanced gene delivery efficiency and anti-tumor effects.
    Mei S; Peng S; Vong EG; Zhan J
    Int Immunopharmacol; 2024 Aug; 137():112393. PubMed ID: 38852522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K
    Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.